314 related articles for article (PubMed ID: 23706946)
1. Incidence of choroidal neovascularization in the fellow eye in the comparison of age-related macular degeneration treatments trials.
Maguire MG; Daniel E; Shah AR; Grunwald JE; Hagstrom SA; Avery RL; Huang J; Martin RW; Roth DB; Castellarin AA; Bakri SJ; Fine SL; Martin DF;
Ophthalmology; 2013 Oct; 120(10):2035-41. PubMed ID: 23706946
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenetics for genes associated with age-related macular degeneration in the Comparison of AMD Treatments Trials (CATT).
Hagstrom SA; Ying GS; Pauer GJT; Sturgill-Short GM; Huang J; Callanan DG; Kim IK; Klein ML; Maguire MG; Martin DF;
Ophthalmology; 2013 Mar; 120(3):593-599. PubMed ID: 23337555
[TBL] [Abstract][Full Text] [Related]
3. Growth of geographic atrophy in the comparison of age-related macular degeneration treatments trials.
Grunwald JE; Pistilli M; Ying GS; Maguire MG; Daniel E; Martin DF;
Ophthalmology; 2015 Apr; 122(4):809-16. PubMed ID: 25542520
[TBL] [Abstract][Full Text] [Related]
4. Genetic influences on the outcome of anti-vascular endothelial growth factor treatment in neovascular age-related macular degeneration.
Abedi F; Wickremasinghe S; Richardson AJ; Islam AF; Guymer RH; Baird PN
Ophthalmology; 2013 Aug; 120(8):1641-8. PubMed ID: 23582991
[TBL] [Abstract][Full Text] [Related]
5. Risk of scar in the comparison of age-related macular degeneration treatments trials.
Daniel E; Toth CA; Grunwald JE; Jaffe GJ; Martin DF; Fine SL; Huang J; Ying GS; Hagstrom SA; Winter K; Maguire MG;
Ophthalmology; 2014 Mar; 121(3):656-66. PubMed ID: 24314839
[TBL] [Abstract][Full Text] [Related]
6. Single-Nucleotide Polymorphisms Associated With Age-Related Macular Degeneration and Lesion Phenotypes in the Comparison of Age-Related Macular Degeneration Treatments Trials.
Maguire MG; Ying GS; Jaffe GJ; Toth CA; Daniel E; Grunwald J; Martin DF; Hagstrom SA;
JAMA Ophthalmol; 2016 Jun; 134(6):674-81. PubMed ID: 27099955
[TBL] [Abstract][Full Text] [Related]
7. Macular Morphology and Visual Acuity in the Second Year of the Comparison of Age-Related Macular Degeneration Treatments Trials.
Sharma S; Toth CA; Daniel E; Grunwald JE; Maguire MG; Ying GS; Huang J; Martin DF; Jaffe GJ;
Ophthalmology; 2016 Apr; 123(4):865-75. PubMed ID: 26783095
[TBL] [Abstract][Full Text] [Related]
8. Macular Morphology and Visual Acuity in Year Five of the Comparison of Age-related Macular Degeneration Treatments Trials.
Jaffe GJ; Ying GS; Toth CA; Daniel E; Grunwald JE; Martin DF; Maguire MG;
Ophthalmology; 2019 Feb; 126(2):252-260. PubMed ID: 30189282
[TBL] [Abstract][Full Text] [Related]
9. Incidence and Progression of Nongeographic Atrophy in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) Clinical Trial.
Daniel E; Maguire MG; Grunwald JE; Toth CA; Jaffe GJ; Martin DF; Ying GS;
JAMA Ophthalmol; 2020 May; 138(5):510-518. PubMed ID: 32191267
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive analysis of complement factor H and LOC387715/ARMS2/HTRA1 variants with respect to phenotype in advanced age-related macular degeneration.
Andreoli MT; Morrison MA; Kim BJ; Chen L; Adams SM; Miller JW; DeAngelis MM; Kim IK
Am J Ophthalmol; 2009 Dec; 148(6):869-74. PubMed ID: 19796758
[TBL] [Abstract][Full Text] [Related]
11. Baseline predictors for one-year visual outcomes with ranibizumab or bevacizumab for neovascular age-related macular degeneration.
Ying GS; Huang J; Maguire MG; Jaffe GJ; Grunwald JE; Toth C; Daniel E; Klein M; Pieramici D; Wells J; Martin DF;
Ophthalmology; 2013 Jan; 120(1):122-9. PubMed ID: 23047002
[TBL] [Abstract][Full Text] [Related]
12. Association of Single-Nucleotide Polymorphisms in Age-Related Macular Degeneration With Pseudodrusen: Secondary Analysis of Data From the Comparison of AMD Treatments Trials.
Lin LY; Zhou Q; Hagstrom S; Maguire MG; Daniel E; Grunwald JE; Martin DF; Ying GS;
JAMA Ophthalmol; 2018 Jun; 136(6):682-688. PubMed ID: 29801032
[TBL] [Abstract][Full Text] [Related]
13. Incidence of new choroidal neovascularization in fellow eyes of patients treated in the MARINA and ANCHOR trials.
Barbazetto IA; Saroj N; Shapiro H; Wong P; Ho AC; Freund KB
Am J Ophthalmol; 2010 Jun; 149(6):939-946.e1. PubMed ID: 20378094
[TBL] [Abstract][Full Text] [Related]
14. Risk of geographic atrophy in the comparison of age-related macular degeneration treatments trials.
Grunwald JE; Daniel E; Huang J; Ying GS; Maguire MG; Toth CA; Jaffe GJ; Fine SL; Blodi B; Klein ML; Martin AA; Hagstrom SA; Martin DF;
Ophthalmology; 2014 Jan; 121(1):150-161. PubMed ID: 24084496
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of eyes with lesions composed of >50% blood in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT).
Altaweel MM; Daniel E; Martin DF; Mittra RA; Grunwald JE; Lai MM; Melamud A; Morse LS; Huang J; Ferris FL; Fine SL; Maguire MG; ;
Ophthalmology; 2015 Feb; 122(2):391-398.e5. PubMed ID: 25307130
[TBL] [Abstract][Full Text] [Related]
16. Genetic analysis of simultaneous geographic atrophy and choroidal neovascularization.
Grob S; Luo J; Hughes G; Lee C; Zhou X; Lee J; Du H; Ferreyra H; Freeman WR; Kozak I; Zhang K
Eye (Lond); 2012 Aug; 26(8):1106-13. PubMed ID: 22699975
[TBL] [Abstract][Full Text] [Related]
17. The effect of CFH polymorphisms on the response to the treatment of age-related macular degeneration (AMD) with intravitreal ranibizumab.
Dikmetas O; Kadayıfcılar S; Eldem B
Mol Vis; 2013; 19():2571-8. PubMed ID: 24367156
[TBL] [Abstract][Full Text] [Related]
18. Association of complement factor H and LOC387715 genotypes with response of exudative age-related macular degeneration to intravitreal bevacizumab.
Brantley MA; Fang AM; King JM; Tewari A; Kymes SM; Shiels A
Ophthalmology; 2007 Dec; 114(12):2168-73. PubMed ID: 18054635
[TBL] [Abstract][Full Text] [Related]
19. Outer retinal tubulation in the comparison of age-related macular degeneration treatments trials (CATT).
Lee JY; Folgar FA; Maguire MG; Ying GS; Toth CA; Martin DF; Jaffe GJ;
Ophthalmology; 2014 Dec; 121(12):2423-31. PubMed ID: 25064723
[TBL] [Abstract][Full Text] [Related]
20. Incidence and Growth of Geographic Atrophy during 5 Years of Comparison of Age-Related Macular Degeneration Treatments Trials.
Grunwald JE; Pistilli M; Daniel E; Ying GS; Pan W; Jaffe GJ; Toth CA; Hagstrom SA; Maguire MG; Martin DF;
Ophthalmology; 2017 Jan; 124(1):97-104. PubMed ID: 28079023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
